Genetic Technologies

$3.25
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.13 (+4.10%) Today
-$0.05 (-1.52%) As of 8:00 PM EST after-hours

Why Robinhood?

You can buy or sell GENE and other stocks, options, and ETFs commission-free!

About GENE

Genetic Technologies Ltd Sponsored ADR, also called Genetic Technologies, is a molecular diagnostics company that offers predictive testing and assessment tools to help physicians proactively manage women's health. It operates through the USA and Australia geographical segments. The firm's product BREVAGenplus, is a clinically validated risk assessment test for non-hereditary breast cancer. The company was founded on January 5, 1987 and is headquartered in Fitzroy, Australia. The listed name for GENE is Genetic Technologies Ltd Sponsored ADR.

CEO
Jerzy Muchnicki
Employees
Headquarters
Fitzroy, Victoria (VIC)
Founded
1987
Market Cap
45.44M
Price-Earnings Ratio
Dividend Yield
Average Volume
253.72K
High Today
$3.37
Low Today
$3.20
Open Price
$3.37
Volume
824.00K
52 Week High
$10.30
52 Week Low
$1.41

Collections

You May Also Like